FDA Criticized For Slow Approvals But Allows 21 New Drugs This Year (PharmaceuticalOnline)
No doubt, 2008 has been a rough year just about everywhere, with slings and arrows targeting everybody from an ambitious plumber to the president.

FDA Submission Of Isosulfan Blue Injection ANDA (Medical News Today)
Synerx Pharma, LLC announces the submission to the FDA of Isosulfan Blue Injection (generic equivalent to Lymphazurin , Covidien (formerly US Surgical)). This ANDA submission is the culmination of a four year joint effort by Synerx Pharma, LLC and its exclusive raw material supplier Apicore, LLC.